Skip to main content
Xcure Corp. logo

Xcure Corp. — Investor Relations & Filings

Ticker · 070300 ISIN · KR7070300009 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 330 across all filing types
Latest filing 2024-03-20 Audit Report / Informat…
Country KR South Korea
Listing KO 070300

About Xcure Corp.

https://xcure.co.kr/en/

Xcure Corp. is a digital security solutions company specializing in smart card technology and security platforms. The company develops and provides products such as Universal Subscriber Identity Module (USIM) cards, eSIMs, and high-capacity dual-interface smart cards. A key innovation includes the development of the world's first USIM combi smart chip. Xcure's offerings extend to mobile security platforms, IoT security solutions, and smart card-based loyalty management systems. The company primarily serves the telecommunications and finance sectors, leveraging its expertise in semiconductor technology and secure platform development.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted by the company X-Cure. It provides a summary of the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor. While it contains financial data, it is a standard regulatory disclosure announcement in the Korean market (DART system) confirming the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it is classified as an Audit Report / Information document. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive financial report titled '재무제표에 대한 감사보고서' (Audit Report on Financial Statements) for X-Cur Co., Ltd. It includes the independent auditor's report, balance sheet, income statement, statement of changes in equity, cash flow statement, and detailed notes to the financial statements for the fiscal year ending December 31, 2023. While it contains an audit report, the inclusion of the full set of financial statements and notes indicates it is the primary annual financial reporting document, which is classified as an Annual Report (10-K) in this schema. FY 2023
2024-03-20 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (X-Secure) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides specific financial data comparing the current and previous fiscal years and explains the reasons for the variance. It is not a full annual report, but rather a specific regulatory disclosure of financial performance highlights, fitting the 'Earnings Release' (ER) category as it serves as the initial announcement of financial results. FY 2023
2024-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for X-Cure Co., Ltd. It contains the agenda for the upcoming Annual General Meeting (AGM), including reports on financial statements, board appointments, and governance matters. While it contains financial data, it is primarily a proxy solicitation and meeting notice document sent to shareholders to inform them of the meeting and request their participation/votes. In the context of the provided categories, this fits the definition of a Proxy Solicitation & Information Statement.
2024-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy/Voting Rights). It contains information regarding the solicitation of proxies for an upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting methods (electronic/written), and details about the solicitors. While it includes financial statements as reference material for the shareholders, the primary purpose of the document is to solicit proxies for the AGM, which falls under the Proxy Solicitation & Information Statement category.
2024-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company X-Cure. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) to be voted on at the upcoming meeting. This document serves as the official proxy solicitation and meeting notice provided to shareholders, which falls under the Proxy Solicitation & Information Statement category.
2024-03-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.